Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors
Zhiqiang Zhao1, Dmitri A Pissarnitski1, Hubert B Josien1
1Department of Medicinal Chemistry, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA.
Researchers developed novel 4-morpholine sulfonamide γ-secretase inhibitors (GSIs) that reduce CYP liabilities and amyloid-beta (Aβ) in an Alzheimer
Area of Science:
- Medicinal Chemistry
- Neuroscience
- Pharmacology
Background:
- γ-secretase inhibitors (GSIs) are investigated for Alzheimer's disease (AD) treatment.
- Previous GSI series exhibited CYP liabilities and suboptimal activity.
- Optimizing GSI profiles is crucial for therapeutic development.
Purpose of the Study:
- To design, synthesize, and characterize a novel series of substituted 4-morpholine sulfonamide GSIs.
- To improve the pharmacological profile, including reduced CYP liabilities and enhanced γ-secretase inhibition.
- To evaluate the in vivo efficacy of selected compounds in an Alzheimer's disease animal model.
Main Methods:
- Structure-activity relationship (SAR) studies were conducted.
- Synthesis of a novel series of 4-morpholine sulfonamides.
- In vitro assays for γ-secretase inhibition and CYP liability assessment.
- In vivo studies in transgenic AD animal models to measure amyloid-beta (Aβ) reduction.
Main Results:
- The novel 4-morpholine sulfonamide series demonstrated improved γ-secretase inhibition.
- Several compounds showed reduced cytochrome P450 (CYP) liabilities compared to previous series.
- Selected inhibitors significantly reduced amyloid-beta (Aβ) levels after oral administration in an AD model.
Conclusions:
- Substituted 4-morpholine sulfonamides represent a promising class of GSIs.
- This series offers potential for improved therapeutic index in Alzheimer's disease treatment.
- Further development of these compounds may lead to effective AD therapies.
More Related Videos
11:57Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
11:04Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
Published on: June 13, 2022
Related Concept Videos
Preparation of 1° Amines: Gabriel Synthesis
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Preparation and Reactions of Sulfides
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Amines to Sulfonamides: The Hinsberg Test
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
